Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2012

View Archived Issues

Trius Therapeutics synthesizes novel dual-target antibacterial agents

MM-433593 human pharmacokinetic data presented

NEPTUNE I and II data on tamsulosin/solifenacin presented

Ono Pharmaceutical designs novel E-NPP 2 inhibitors

New data on onabotulinumtoxinA reveals benefits on patient-reported outcomes

Further clinical data on dapagliflozin available

Research at Ortho-McNeil-Janssen Pharmaceuticals yields new gamma secretase modulators

Variations in MYH11/NDE1 and MUC16 loci are linked to common epilepsy

Novel candidate anticancer drugs patented

MRC Technology presents new antimalarials

Novel GABA(A) receptor modulators synthesized by team of French researchers

CHMP recommends Bayer's anticoagulant for additional use

Merck Serono to support Auxogyn's fertility test

Tresiba and Ryzodeg receive positive CHMP opinions

Millennium begins phase III MLN-9708 study

A novel derivative of M6G shows analgesic potency

CHMP recommends Abbott's Humira in pediatric Crohn's disease

EMA's CHMP recommends approval of Amyvid

Summit receives second award from the Wellcome Trust for C. difficile antibiotic program

Astellas set to launch Gonax in Japan

BiondVax and MonoSol Rx to collaborate on oral film formulation of universal flu vaccine

Astellas and AIST to collaborate on discovering drugs for neglected tropical diseases

Mirabegron recommended for European approval

TNI BioTech and Hubei Qianjiang Pharmaceuticals to jointly develop anticancer drugs in China

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...